A detailed history of Winthrop Advisory Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Winthrop Advisory Group LLC holds 285 shares of REGN stock, worth $200,027. This represents 0.04% of its overall portfolio holdings.

Number of Shares
285
Previous 287 0.7%
Holding current value
$200,027
Previous $301,000 0.66%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$1024.09 - $1201.76 $2,048 - $2,403
-2 Reduced 0.7%
285 $299,000
Q2 2024

Jul 18, 2024

SELL
$883.2 - $1071.19 $7,065 - $8,569
-8 Reduced 2.71%
287 $301,000
Q1 2024

Apr 17, 2024

SELL
$902.69 - $993.35 $4,513 - $4,966
-5 Reduced 1.67%
295 $283,000
Q4 2023

Jan 10, 2024

BUY
$775.18 - $881.7 $232,553 - $264,510
300 New
300 $263,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Winthrop Advisory Group LLC Portfolio

Follow Winthrop Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winthrop Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winthrop Advisory Group LLC with notifications on news.